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Objective:Hospital readmission after lower extremity bypass is a large cost burden and has become a focal point for policy
change directed at disease-speciﬁc bundling strategies. The purpose of this study was to evaluate rates and predictors of
30-day readmission from a large, multicenter trial data set.
Methods: We analyzed the PRoject of Ex-Vivo vein graft ENgineering via Transfection III (PREVENT III) data set of
1404 critical limb ischemia (CLI) patients undergoing lower extremity vein graft bypass at 83 North American centers.
The primary end point was readmission #30 days of discharge. Secondary end points included graft patency and limb
salvage evaluated in the context of readmission. The data set was split into a two-thirds derivation set and a one-third
validation set for the purposes of creating a risk prediction model. A whole number integer risk score was assigned to
independent predictors of readmission. Summary risk scores were collapsed into categories and deﬁned as low (0-1
points), medium (2-5 points), and high (>5 points).
Results: We analyzed 1356 vein graft bypass patients, of which 23 (1.7%) died in-hospital and were excluded from the
readmission analyses. In the derivation data set of 866 patients, 211 (24.4%) were readmitted#30 days of discharge. The
most common reasons for readmission were wound infection in index leg (39.8%), an additional procedure in the index
leg (20.8%), and nonvascular reasons (19%). By multivariable analysis, factors associated with 30-day hospital read-
mission (odds ratio [95% conﬁdence limits]) included female gender (1.5 [1.0, 2.1]), current smoking (1.6 [1.1, 2.4]), in-
hospital loss of graft patency (1.8 [1.0, 3.2]), dialysis (2.0 [1.2, 3.2]), and tissue loss (1.7 [1.1, 2.5]). In the derivation
set, rates of readmission correlated to risk category. The 30-day readmission rates were 15.6% for low-risk patients (0-1
points), 24.1% for moderate-risk (2-5 points) patients, and 38.0% for high-risk (>5 points) patients. Similarly, in the
validation set, the rates were 16.5%, 25.4%, and 38.1% for low-, medium-, and high-risk groups, respectively. Thirty-day
readmission was not associated with loss of long-term graft patency but was associated with long-term limb loss (hazard
ratio, 2.1; 95% conﬁdence interval, 1.4-3.1; P [ .0002).
Conclusions: Readmission after lower extremity bypass for CLI is common (24%). Certain characteristics, such as female
gender, current smoking, dialysis-dependence, tissue loss, and in-hospital graft-related events, are associated with
increased risk. Readmission is associated with long-term limb loss. These data provide benchmark values for this complex
patient population and may prove useful when hospital readmission is used as a quality metric for hospital perform-
ance. (J Vasc Surg 2013;57:1481-8.)Thirty-day hospital readmission has been identiﬁed as
a performance measure for institutions and a target of
reimbursement-based improvement incentives that will
come to bear in the near future.1 This is of particular
interest to vascular surgeons because the rate for readmis-
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A recent institutional-based report evaluated an array of
vascular surgery procedures to identify factors that were asso-
ciated with the highest rate of unplanned readmission.3
Although the authors did not report speciﬁc risk factors strat-
iﬁed by intervention, they found that the vascular surgical
procedure with the highest rate of unplanned readmission,
at >14%, was lower extremity revascularization. Our group
recently reported from our own institution (Brigham
and Women’s Hospital) that the overall rate of unplanned
readmission in 1543 lower extremity bypasses was 23%.
The most strongly associated factors included surgical site
infections and early postoperative graft-related events.4
A recently published conceptual framework by Brooke
et al5 identiﬁed a lack of clearly deﬁned or validated risk
factors to accurately predict hospital readmission in vascular
surgery as a whole. Recommendations from their article
identiﬁed the need to distinguish between procedure types
and the need to focus on patient-level factors, including
socioeconomic and baseline functional characteristics, in
addition to comorbid conditions because the inclusion of1481
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nating prediction model.6
The purpose of the current study was to create a simple
risk prediction model to determine the factors that predict
30-day readmission after lower extremity bypass surgery
using a cohort from a previously conducted randomized
controlled trial.
METHODS
Database. This study was a retrospective cohort anal-
ysis using data from a previously conducted multi-
institutional randomized controlled trial, the PRoject of
Ex-Vivo vein graft ENgineering via Transfection III
(PREVENT III).7 The details of the PREVENT III data-
base have been previously described7,8 and included 1404
patients who underwent lower extremity bypass surgery
with a vein graft for critical limb ischemia (CLI) (rest pain,
ulceration, or gangrenous tissue loss). Follow-up informa-
tion was available for up to 1 year. For the current study, 48
patients who underwent bypass at Brigham and Women’s
Hospital were excluded because their data were previously
analyzed for a similar work.4
End points. The primary end point was hospital read-
mission#30 days of the date of discharge. The readmission
analysis excluded 23 patients who died during the index
hospitalization. Each patient was considered only once in
this analysis. Secondary end points included primary, assis-
ted primary, and secondary patency rates and limb salvage
out to 1 year of follow-up. Graft patency was deﬁned using
standard criteria.9
Statistical analysis. Categoric variables were compared
using c2 or the Fisher exact test, where appropriate. Contin-
uous variables were compared using the two-tailed Student
t-test. Univariate predictors of 30-day readmission were
analyzed using unadjusted odds ratios (ORs). For multi-
variable analysis, continuous variables, such as age, weight
(kilograms), length of stay (days), operative time (minutes),
and quality of life characteristics, were dichotomized using
the 75th percentile as the cut point. In-hospital graft events
were deﬁned as loss of primary, assisted, or secondary
patency before the date of discharge from the index
admission. Ordinal variables were collapsed into dichoto-
mous variables for the purpose of risk score development.
Patency and limb salvage rates were compared using the log-
rank test. A Cox proportional hazard model was created to
evaluate predictors of the secondary end point of limb
salvage. This was performed by backward elimination
technique using P < .05 for inclusion in the ﬁtted model.
Factors included in the model were readmission status, age,
sex, race, smoking status, dialysis-dependence, diabetes,
hypertension, coronary artery disease/myocardial infarction
(MI), tissue loss indication, prior bypass, inﬂow vessel,
outﬂow vessel, postoperative MI, stroke, graft failure,
wound infection, and length of stay.
Risk prediction model. To create and subsequently
test our risk prediction model for hospital readmission after
lower extremity bypass, the initial cohort was randomly
divided into separate derivation and validation data sets.The derivation set (n ¼ 866) contained two-thirds of the
patients and the validation set (n ¼ 467) contained the
remaining one-third of the initial total cohort. A multi-
variable logistic regression model with hospital readmission
as the dependent variable was created using a backward
elimination technique. A value of P < .25 was used as the
cut point for elimination. Factors included in the elimina-
tion model were age, sex, race, diabetes, baseline weight,
hypertension, previous MI, dialysis-dependence, surgical
indication (tissue loss vs rest pain), hyperlipidemia, hyper-
cholesterolemia, liver disease, current smoking, baseline
activity score, baseline pain score and baseline emotional
score derived from the Vascular Quality of Life Question-
naire,10 inﬂow artery, outﬂow artery, vein quality (<3 vs
>3 mm) length of surgery, hospital length of stay, hospital
type (private vs academic), concomitant debridement
procedure, in-hospital wound infection, in-hospital MI,
and in-hospital stroke.
Signiﬁcant multivariable predictors of readmission were
used to create whole-number risk scores. The b-coefﬁcient
for each signiﬁcant factor in the ﬁnal model was divided by
the smallest predictive b-coefﬁcient (female gender) and
the result was rounded to the nearest whole number,
a technique that has been previously described.11-13 Each
patient in the derivation and validation set was issued an
overall risk score by summing their risk factors. These
summary scores were used to divide the patients into three
clinically relevant groups to create low-, medium-, and
high-risk groups for 30-day readmission. Model discrimi-
nation was assessed with the area under the receiver oper-
ating characteristic curve represented as the C statistic. The
ﬁt of the model was assessed using the Hosmer-Lemeshow
goodness-of-ﬁt test.
Internal validation. The calculated risk score for 30-
day readmission based on the derivation set was applied
to the validation set to allow for comparison between the
two groups. Discrimination of the model in the validation
set was assessed by the C statistic. Model calibration was
assessed with observed-to-expected rates of readmission as
a function of the designated risk categories in the deriva-
tion and validation data sets. The three points on the
observed vs expected ﬁgures represent low-, medium-, and
high-risk groups.RESULTS
After the 48 Brigham and Women’s Hospital patients
were excluded from the 1404 in the PREVENT III cohort,
the remaining 1356 patients comprised the cohort of
interest for this study. Table I reports the baseline char-
acteristics of patients randomly assigned to the derivation
(two-thirds) and validation (one-third) data sets. The
baseline characteristics for the derivation and validation
sets were similar. Both groups were predominantly male
(>60%; P ¼ .63), with similar rates of diabetes (>60%;
P ¼ .68), current smoking (>25%; P ¼ .1), dialysis depen-
dence (w12%; P ¼ .93), and tissue loss indications (>70%;
P ¼ .74). The 23 patients (1.7%) who died in-hospital after
Table I. Baseline characteristics of lower extremity
bypass patients in the derivation and validation data sets
Variablea
Derivation
set
(n ¼ 881)
Validation
set
(n ¼ 475) P
Age, years
Mean (SD) 68.5 (11.6) 68.1 (11.6) .60
Median (range) 69 (26-99) 69 (30-95)
Gender .63
Male 569 (64.6) 300 (63.2)
Female 312 (35.4) 175 (36.8)
Race .04
White 618 (70.1) 359 (75.6)
Non-white 263 (29.9) 116 (24.4)
Comorbid conditions
Diabetes mellitus 565 (64.1) 299 (63.0) .68
Current smoker 223 (25.4) 142 (29.9) .1
Hypertension 732 (83.1) 370 (77.9) .02
Prior MI 268 (30.4) 142 (29.9) .85
Current dialysis-dependence 108 (12.3) 59 (12.4) .93
Hyperlipidemia 389 (44.4) 209 (44.1) .95
Hypercholesterolemia 396 (45.1) 198 (41.9) .39
Indication for procedure .40
Rest pain 218 (24.8) 125 (26.5)
Nonhealing ulcer 338 (38.4) 186 (39.4)
Gangrene 323 (36.8) 161 (34.1)
Prior infrainguinal
reconstruction
242 (27.5) 123 (25.9) .56
Technical details
Inﬂow vessel .25
Common femoral artery 414 (47.0) 252 (53.0)
Superﬁcial femoral artery 226 (26.6) 104 (21.9)
Profunda femoral artery 35 (4.0) 20 (4.2)
Other 206 (23.4) 99 (20.8)
Recipient artery .57
Popliteal artery
Above knee 89 (10.1) 54 (11.4)
Below knee 197 (22.4) 104 (21.9)
Tibial 461 (52.3) 258 (54.2)
Pedal 108 (12.2) 52 (11.0)
Other 26 (3.0) 7 (1.5)
MI, Myocardial infarction; SD, standard deviation.
aData are shown as number (%) and continuous data as indicated.
Table II. Unadjusted odds ratios of 30-day readmission
in the derivation data set
Variables OR (95% CL) P
Preoperative characteristics
Demographics
Age $ 75 (vs <75) years 1.0 (0.72, 1.4) >.99
Female gender (vs male) 1.5 (1.1, 2.0) .019
Non-white race (vs white) 1.2 (0.83, 1.6) .39
Comorbid conditions
Diabetes mellitus (vs none) 1.3 (0.94, 1.8) .11
Current smoker (vs none) 1.1 (0.79, 1.6) .53
Hypertension (vs none) 1.2 (0.77, 1.8) .44
Previous MI (vs none) .99 (0.71, 1.4) .97
Current dialysis (vs none) 1.7 (1.1, 2.6) .016
Indication for procedure
Tissue loss (vs rest pain) 1.3 (0.93, 2.0) .11
Operative characteristics
Prior infrainguinal reconstruction .75 (0.52, 1.1) .11
CFA inﬂow (vs other) .84 (0.61, 1.1) .26
Popliteal outﬂow (vs other) .80 (0.57, 1.1) .21
Surgery length >5.25 hours
(vs <5.25 hours)
1.1 (0.76, 1.5) .69
Normal completion study (vs none) 1.0 (0.76, 1.4) .80
Postoperative factors
Discharged on oral anticoagulant 1.1 (0.80, 1.6) .50
In-hospital wound infection .98 (0.56, 1.7) .94
In-hospital MI .76 (0.36, 1.6) .47
In-hospital graft event 1.9 (1.2, 3.1) .01
CFA, Common femoral artery; CL, conﬁdence limits; MI, myocardial
infarction; OR, odds ratio.
Table III. Multivariable predictors of 30-day
readmission and risk score calculation in the derivation
data set
Predictor b-coefﬁcient
Integer
score OR (95% CL)
Female (vs male) .190 1 1.5 (1.0, 2.1)
Current smoker (vs not) .241 1 1.6 (1.1, 2.4)
Dialysis-dependent
(vs not)
.341 2 2.0 (1.2, 3.2)
In-hospital graft event
(vs none)
.300 2 1.8 (1.0, 3.2)
Tissue loss (vs rest pain) .506 3 1.7 (1.1, 2.5)
CL, Conﬁdence limits; OR, odds ratio.
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analyses.
In the two-thirds derivation data set (n ¼ 866), the
overall rate of 30-day readmission was 24.4% (n ¼ 211).
The reasons for readmission were wound infection in the
index leg (39.8%), an additional procedure in the index
leg (20.8%), nonvascular reasons (19%), index graft failure
(6.2%), procedural (6.2%), new peripheral arterial disease
(2.8%), stroke (2.4%), MI (0.96%), and unknown (1.9%).
Univariate analysis of the derivation data set showed the
factors that were signiﬁcantly associated with 30-day read-
mission were (OR [95% conﬁdence limits]): female gender
(1.5 [1.1, 2.0]; P ¼ .019), dialysis-dependence (1.7 [1.1,
2.6]; P ¼ .016), and in-hospital loss of graft patency (1.9
[1.2, 3.1]; P ¼ .39; Table II).
By multivariable backward elimination, after adjust-
ment for other factors, ﬁve variables were signiﬁcantly
predictive of 30-day readmission in the derivation data
set (OR [95% conﬁdence limits]): female gender (1.5[1.0, 2.1]; P ¼ .036), current smoking (1.6 [1.1, 2.4];
P ¼ .022), dialysis-dependence (2.0 [1.2, 3.2]; P ¼
.006), in-hospital graft event (1.8 [1.0, 3.2; P ¼ .037),
and tissue loss as the surgical indication (1.7 [1.1, 2.5];
P ¼ .02). Table III reports the b-coefﬁcients and calculated
risk scores associated with these factors. Ultimately, female
gender and current smoking status were each assigned
a risk score of 1, dialysis-dependence and in-hospital graft
events were each assigned a risk score of 2, and tissue
loss as the surgical indication was assigned a score of 3.
The potential 30-day readmission risk scores ranged
from 0 to 9. No patients had a score of 9, and only one
patient had a score of 8 (Table IV). The risk scores were
collapsed into three risk groups and deﬁned as low
Table IV. Thirty-day readmission rates based on
calculated risk score
Risk score Total No. Readmission rate, No. (%)
0 63 7 (11.1)
1 91 17 (18.7)
2 36 10 (27.8)
3 273 56 (20.5)
4 235 66 (28.1)
5 93 28 (30.1)
6 61 21 (34.4)
7 9 6 (66.7)
8 1 0
9 0 0
Fig 1. Bar chart reveals similar rates of 30-day readmission for
low-, moderate-, and high-risk categories in the derivation and
validation data sets.
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As shown in Fig 1 in the derivation set, the readmission
rates were 15.6% for lowest-risk group, 25.1% for the
medium-risk group, and 38.0% for the high-risk group.
In the validation set, the readmission rates were 16.5%
for the lowest risk group, 25.4% for the medium-risk
group, and 38.1% for the high-risk group. Table V reports
these rates along with the associated odds of readmission
by risk category for the derivation and validation set.
The ﬁtted model for risk of readmission displayed only
a modest ability to discriminate between those who are
and are not readmitted, with a C statistic of 0.60. This
was associated with a Hosmer-Lemeshow P ¼ .36, indi-
cating the rate of observed-to-expected readmissions in
the derivation set adequately ﬁt the data. The validation
set also displayed only a modest ability to discriminate,
with a C statistic of 0.58. Fig 2 displays the observed vs ex-
pected readmission rates for the derivation and validation
set by risk category, which overall displayed excellent
calibration.
Secondary outcomes. By univariate analysis, patients
who were readmitted #30 days of discharge had similar
rates of 1-year primary patency as those who were not
readmitted (52.4% 6 3.8% vs 56.5% 6 2.1%; P ¼ .10). The
two groups also had similar 1-year rates of assisted primary
patency (72.9% 6 3.3% vs 74.8% 6 1.8%; P ¼ .36) and
secondary patency (77.9% 6 3.1% vs 78.6% 6 1.6%;
P ¼ .34). Patients who were readmitted #30 days had
signiﬁcantly lower rates of limb salvage at 1 year than those
who were not readmitted (78.3% 6 3.0% vs 89.6% 6 1.2%;
P < .0001; Fig 3).
By multivariable Cox regression analysis, 30-day read-
mission remained predictive of long-term limb loss (hazard
ratio [HR], 2.1; 95% conﬁdence interval, 1.4-3.0; P ¼
.0003) after adjustment for other factors. Other predictors
of limb-loss included diabetes, tibial or pedal outﬂow
(vs popliteal), early graft-related events, and index hospital
length of stay >10 days (Table VI).
DISCUSSION
This retrospective cohort study using data from a multi-
center prospective randomized controlled trial has demon-
strated an overall 24% rate of 30-day readmission afterlower extremity bypass for CLI indications. This rate varies
by risk category, with the lowest-risk group demonstrating
a rate of 15.6%, whereas the medium-risk and high-risk
groups had respective rates of 25.1% and 38.0%. Signiﬁcant
predictors of readmission included female gender, dialysis-
dependence, current smoking, tissue loss indications, and
in-hospital graft-related events. After adjustment for other
factors, 30-day readmission was associated with long-term
limb loss.
Readmission to the hospital after medical stays and
surgical procedures has been identiﬁed as a potential area
for quality improvement. Describing readmissions as
“expensive, adverse events for patients,”14 the Centers for
Medicare & Medicaid Services (CMS) has begun public
reporting of risk-adjusted readmission rates after certain
medical conditions, including MI, heart failure, and pneu-
monia. A recent publication by Brooke et al5 appropriately
identiﬁed vascular surgery procedures as a likely target of
this quality metric in the near future. They cited the recent
results of a Medicare claims-based study by Jencks et al,2
which found vascular surgery procedures had the second
highest readmission rate, at 23.9%, of all medical condi-
tions and procedures evaluated as one possible reason for
this specialized interest. Of note in the Medicare study,
rates were not stratiﬁed by procedure type but rather reﬂect
a global readmission rate.
After a comprehensive review of readmissions after
vascular surgery procedures, a recent single-institution
report from the University of Pennsylvania by Jackson
et al3 identiﬁed open lower extremity bypass in conjunction
with CLI as having the highest rate of unplanned readmis-
sion (>14% for both). Our group also recently conducted
a retrospective cohort study from our own institution in
which we found an overall unplanned readmission rate of
Table V. Rates and odds of readmission based on risk class in the derivation and validation data set
Risk
Derivation set Validation set
Readmission rate OR (95% CI) Readmission rate OR (95% CI)
Low (0-1) 15.6 Ref 16.5 Ref
Moderate (2-5) 25.1 1.8 (1.1-2.9) 25.4 1.7 (0.92-3.1)
High (>5) 38.0 3.3 (1.7-6.3) 38.1 2.9 (1.3-6.6)
CI, Conﬁdence interval; OR, odds ratio.
Fig 2. A, The observed vs expected rate of readmission for the derivation data set. The data points represent low-,
medium-, and high-risk groups. B, The observed vs expected rate of readmission for the validation data set. The data
points represent low-, medium-, and high-risk groups.
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Dialysis-dependence and congestive heart failure were the
preoperative factors most strongly associated with readmis-
sion in that analysis.
The goal in this current study was to more formally
risk-stratify patients using factors that would be known
up until the date of hospital discharge, including preoper-
ative characteristics, intraoperative factors, and in-hospital
postoperative factors, to assess an individual patient’s risk
of readmission on the date of discharge. We found similar
results from the multicenter data set as we did in our own
institutional series, including an overall readmission rate of
24% in the derivation data set. Tissue loss remained a strong
predictor of readmission in both studies, as did dialysis-
dependence and early graft-related events. Unique ﬁndings
in the current multicenter-based work were the association
with readmission of female gender and current smoking.
Although the etiology is unclear, female gender has been
previously shown to be associated with wound complica-
tions in lower extremity bypass surgery,15-17 which was
the most common reason for readmission in this study
(w40%). That current smoking predicted readmission is
not surprising. The untoward effects of current smoking
compared with former or never smokers on wound-
healing are well-described.18,19 Current smoking is also
associated with early graft failure in lower extremitybypass.20 Graft-related and wound-related events were
both common reasons for readmission in this study.
It is noteworthy that even the lowest-risk group in the
derivation and validation data sets had readmission rates
>15%. This indicates that even in the most optimal circum-
stances in lower extremity bypass for CLI, we can expect
a relatively high basal rate of hospital readmission.
It is important to note that the only truly modiﬁable risk
factor of the identiﬁed predictors in this study is tobacco use.
The presence of other factors, such as tissue loss, hemodial-
ysis, in-hospital graft events, and gender may be useful to
identify and predict at-risk patients at the time of discharge.
Identiﬁcation of these risk factors would allow for extra
measures to be taken, such as close clinical follow-up,
increased level of nursing care, or delay of discharge until
ongoing wound/graft or dialysis treatment-related issues
can be addressed. That these characteristics are not modiﬁ-
able is of particular importance from a policy standpoint,
which will ultimately have the goal of decreasing readmis-
sion rates with ﬁnancial penalties. The ﬁndings in this study
could contribute to decision modeling or cost-effectiveness
studies to determine how best to work within the conﬁnes of
these high-risk characteristics. Studies looking speciﬁcally at
the cost-effectiveness of prolonging a hospital stay to further
address a complication or unrelated medical problem vs
earlier discharge and a shorter interval return to care as an
Fig 3. Kaplan-Meier curves demonstrate similar rates of (A) primary patency, (B) assisted primary patency, and (C)
secondary patency for the readmitted vs non-readmitted groups in the derivation set. D, The limb salvage rate was
signiﬁcantly lower in the readmitted group. SE, Standard error.
Table VI. Cox proportional regression for predictors of
limb loss in the derivation set
Predictor HR (95% CI) P
30-day readmission 2.1 (1.4-3.1) .0002
Diabetes 1.8 (1.1-2.9) .015
Dialysis-dependence 1.6 (1.0-2.7) .05
Long length of stay (>10 days) 1.5 (1.0-2.2) .05
Tibial or pedal outﬂow target 1.9 (1.1-3.2) .01
In-hospital graft event 2.3 (1.3-3.8) .002
CI, Conﬁdence interval; HR, hazard ratio.
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over how best to manage the higher-risk patient groups
without unnecessarily penalizing individuals and institutions
that are dedicated to caring for them.
An additional remarkable ﬁnding is the association
between 30-day readmission and long-term limb loss in
this study (HR, 2.1). This was a conﬁrmatory ﬁnding
from the results of our institutional-based study in which
30-day readmission was also predictive of loss of limb
(HR, 1.7).4 In both analyses, this factor stood out even
after adjustment for graft patency. Although no direct
causality is implied, this indicates that readmission to the
hospital is a surrogate reminder of the complexity of this
disease process and may affect long-term outcomes.
It bears mentioning that the degree of discrimination
provided by the ﬁtted model in the derivation set wasonly modest, with a C statistic of 0.60. Likewise, the area
under the receiver operating characteristic curve in the vali-
dation set was even less predictive, at 0.58. This inability to
JOURNAL OF VASCULAR SURGERY
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risk for readmission has been extensively studied in the
medical literature. A recent large systematic review by
Kanasagara et al,6 which evaluated 26 readmission risk
prediction models for medical patients, found that most
models that rely on purely clinical information, such as
comorbidities, generally tended to have poor discriminative
ability. They did note that studies that incorporated more
social factors, such as functional status, social support
network, and living status in their models generally per-
formed better for predicting readmission.21,22 Although
the systematic review excluded surgical studies and is there-
fore not directly comparable to our work, the potential for
poor model performance in surgical studies was appreciated
by Brooke et al5 in their conceptual framework for ideal
risk prediction in vascular surgery. In their recent report,
they commented that “risk standardized readmission rates
in vascular surgery will need to include existing variables
currently collected in most health care systems as well as
contextual variables aimed at measuring social, economic,
and community-based support.”5
In the current study, we did include quality of life vari-
ables in the regression model in an attempt to address this
issue. We included the Vascular Quality of Life Question-
naire baseline activity score, pain score, and emotional
scores that were collected as part of the initial PREVENT
III study. Although the inclusion of these quality of life
variables did improve the C statistic of the ﬁtted model,
none of the measured sociodemographic factors remained
signiﬁcant in the ﬁnal model and, therefore, did not
contribute to the prediction score calculation. It might
be that more granular information, such as income level,
living situation, and more well-deﬁned functional status
parameters, could improve the performance of prediction
models such as ours.
Other limitations in this study include that the initial
PREVENT III study did not capture whether readmissions
were planned or unplanned, which may have contributed
to the limited performance of the risk prediction model
to some degree. That said, we found from our previous
institutional review that just 2.7% of readmissions #30
days of lower extremity bypass were truly planned.4 Simi-
larly, Jackson et al,3 in their single-institution cohort study,
found that overall, only 3% of readmissions after vascular
procedures were planned. On the basis of the data from
these institutional experiences, it is unlikely that planned
readmissions constituted a substantially larger proportion
of the PREVENT III cohort, but the data are simply
unavailable. In addition, the initial PREVENT III study
design excluded claudicant patients as well as planned in
situ vein graft conﬁgurations.23 These exclusions limit the
real-world generalizability of the ﬁndings of this study to
some extent, because in reality, a signiﬁcant portion of
bypass operations occur in claudicant patients and the
choice of vein conﬁguration is entirely up to surgeon pref-
erence. Interestingly, in our prior work, operations per-
formed for claudication (15% of total) still had an
unplanned readmission rate of 13.8%, indicating that othersystemic factors drive the readmission process beyond the
severity of disease in the leg.
In summary, lower extremity bypass procedures for
CLI have a relatively high rate of 30-day hospital readmis-
sion. Patients can be stratiﬁed by readily available risk
factors before discharge to determine how best to address
their disposition and follow-up. The limited performance
of the risk prediction model in discrimination in the valida-
tion set, despite inclusion of available sociodemographic
factors, indicates how complex a medical condition CLI
truly is.
CONCLUSIONS
On the basis of the multi-institutional data, the ex-
pected overall readmission rate after lower extremity bypass
for CLI is >20%. Until reliable models are developed with
a high degree of discrimination for identifying vascular
surgical patients at risk of hospital readmission, policy
makers should be wary of widely instituting ﬁnancial penal-
ties for this difﬁcult-to-predict quality metric.
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Submitted Sep 20, 2012; accepted Nov 14, 2012.INVITED COMMENTARYAhmed M. Abou-Zamzam Jr, MD, Loma Linda, CalifMcPhee et al1 have reviewed the Project of Ex-Vivo graft
Engineering via Transfection III (PREVENT III) database of
patients undergoing lower extremity vein bypass for critical limb
ischemia (CLI) and evaluated the rates and predictors of 30-day
readmissions. In the nearly 1400 patients, there was an overall
30-day readmission rate of 24%. The factors predictive of read-
mission included female gender, current smoking, dialysis-
dependence, in-hospital graft-related events, and tissue loss as an
indication for surgery. A simple scoring system using these values
had a moderate correlation with the readmission rates.
The PREVENT III data have given interesting benchmarks
for outcomes after vein bypass for CLI such as patency rates and
wound complications.2 In the current report, the most common
reason for readmission was wound infection (40%). However,
nearly 21% of readmissions were for an “additional procedure
in the index limb.” This clouds the issue of whether these read-
missions were planned or unplanned. In many instances, patients
with CLI require multiple interventions for limb salvage. Thus,
patients who require minor foot amputations as a routine part
of their treatment were identiﬁed as readmissions. However,
the PREVENT III database did not discriminate between
planned and unplanned readmissions. To overcome this, the
authors point to a report of their own experience with >1500
bypasses with a 23% readmission rate in which only 3% of read-
missions were planned.3 Although this may be true at their insti-
tution, extrapolation to the PREVENT III trial may not be
reliable.
Only a prospective study with unplanned readmission as
a primary end point would solve this issue, and more data, such
as in the current report, are necessary to lay the groundwork for
meaningful outcomes benchmarks in CLI. The current report
demonstrates that although the predictors of readmission cannot
be modiﬁed, they can be identiﬁed at the time of discharge.
This may help target patients who need special postdischarge
care or delayed discharge to prevent readmission. In fast-track
colon surgery, a simple measure, such as extending the length
of stay by 1 day, reduced readmission rates in half.4 Perhapsfurther studies in CLI will identify similar measures to avoid
readmissions.
The relevance of this current report rests on the very real
impact that value-based purchasing is having on hospitals and
providers. Identifying readmissions #30 days as a measure of
quality of care is currently being done for acute myocardial infarc-
tion, heart failure, and pneumonia. Centers for Medicare and
Medicaid Services has proposed “hospital-wide all-cause un-
planned readmission” as a measure to be followed beginning in
ﬁscal year 2015.5 To have relevant core measures, the anticipated
outcomes must be known to identify provider outliers. Perhaps
patients with CLI and other conditions requiring multiple planned
interventions should be excluded from certain metrics. In view of
value-based purchasing, having good data on a wide scale will help
protect our best-intentioned treatments from unnecessary punitive
measures when providing care to patients with CLI.REFERENCES
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